Evidence map›Paper›PMID 36702572›Full record

SynthesisClinical chemistry2023

Sex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women.

Jie Li, Lingling Zheng, Kei Hang Katie Chan, Xia Zou, Jihui Zhang, Jundong Liu, Qingwei Zhong, Tracy E Madsen, Wen-Chih Wu, JoAnn E Manson and 2 more

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Clinical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Adverse Cardiometabolic Outcomes in Men With Sisters With Polycystic Ovary Syndrome.The Journal of clinical endocrinology and metabolism · 2025
    Article
  6. Testosterone, sex hormone-binding globulin, and fracture risk in men: evidence from observational and Mendelian randomization analyses.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Jie LiGlobal Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.ORCID 0000-0002-7529-6040
Lingling ZhengGlobal Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Kei Hang Katie ChanDepartment of Epidemiology and Center for Global Cardiometabolic Health, School of Public Health, Brown University, Providence, RI, USA.
Xia ZouGlobal Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Jihui ZhangGuangdong Mental Health Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.ORCID 0000-0002-4976-3039
Jundong LiuDepartments of Biomedical Sciences and Electrical Engineering, City University of Hong Kong, Hong Kong SAR, China.
Qingwei ZhongGlobal Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Tracy E MadsenDepartment of Epidemiology and Center for Global Cardiometabolic Health, School of Public Health, Brown University, Providence, RI, USA.
Wen-Chih WuDepartment of Epidemiology and Center for Global Cardiometabolic Health, School of Public Health, Brown University, Providence, RI, USA.ORCID 0000-0002-2834-2024
JoAnn E MansonDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Xueqing YuGlobal Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Simin LiuGlobal Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.ORCID 0000-0003-2098-3844
Guangdong Academy of Medical Sciences · CNBrown University · USCity University of Hong Kong · HKBrigham and Women's Hospital · US

Funding

A nested case-control study of exposure to toxic metals, essential metals and their interaction on the risk of type 2 diabetesR01ES029082 · NIEHS · BROWN UNIVERSITY · PI LIU, SIMIN, YANA, BAI · 2019 to 2022
$2.1M
Asprosin, body weight, and risk of type 2 diabetes in U.S. men and womenR01DK125403 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI CHOPRA, ATUL, LIU, SIMIN · 2020 to 2022
$2.1M
StoP STRokE: Sex-Specific Prevention of Stroke Through Reproductive Risk Factors and Sex Hormone EffectsK23HL140081 · NHLBI · RHODE ISLAND HOSPITAL · PI MADSEN, TRACY · 2018 to 2022
$945k
Environmental heavy metals and risk of ischemic heart disease and stroke in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)R01ES031391 · NIEHS · BROWN UNIVERSITY · PI LIU, SIMIN, LOTUFO, PAULO ANDRADE · 2020 to 2023
$695k
Medical Research Council MC_PC_17228Medical Research Council MC_QA137853NHLBI NIH HHS K23 HL140081NIDDK NIH HHS R01 DK125403NIEHS NIH HHS R01 ES029082NIEHS NIH HHS R01 ES031391
6 · The paper itself

Abstract

backgroundThe role of sex hormone-binding globulin (SHBG) levels in clinical risk stratification and intervention for coronary heart disease (CHD) remains uncertain. We aimed to examine whether circulating levels of SHBG are predictive of CHD risk in men and women.

methodsWe investigated the association between SHBG and the risk of incident CHD in 128 322 men and 135 103 women free of CHD at baseline in the prospective United Kingdom Biobank (UKB) cohort. The unconfounded associations were estimated using Mendelian randomization (MR) analysis. We further conducted a meta-analysis to integrate currently available prospective evidence. CHD events included nonfatal and fatal myocardial infarction and coronary revascularization.

resultsIn the UKB, during a median of 11.7 follow-up years, 10 405 men and 4512 women developed CHD. Serum levels of SHBG were monotonically associated with a decreased risk of CHD in both men (adjusted hazard ratio [HR] per log nmol/L increase in SHBG: 0.88 [0.83-0.94]) and women (HR: 0.89 [0.83-0.96]). MR-based analyses suggested causality and a dose-response relationship of SHBG with CHD risk. A cumulative meta-analysis including 216 417 men and 138 282 women from 11 studies showed that higher levels of SHBG were prospectively associated with decreased CHD risk in men comparing the highest with the lowest quartile: pooled relative risk (RR) 0.81 (0.74-0.89) and women (pooled RR: 0.86 [0.78-0.94]).

conclusionsHigher circulating SHBG levels were directly and independently predictive of lower CHD risk in both men and women. The utility of SHBG for CHD risk stratification and prediction warrants further study.

Indexed as

Coronary DiseaseMyocardial InfarctionHumansProspective StudiesRiskRisk FactorsSex Hormone-Binding GlobulinSex Hormone-Binding Globulincoronary heart diseaseendogenousmenMendelian randomization analysisSHBGwomen

Identifiers

PMID36702572
PMCPMC11599539
OpenAlexW4318173985

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.